The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Osipova V.V.

Research Department of Neurology, Scientific Research Center, I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Moscow Research Clinical Centre for Neuropsychiatry, Moscow Health Department, Moscow, Russia

Filatova E.G.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Artemenko A.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Lebedeva E.R.

Department of Neurology and Neurosurgery, The Urals State Medical University, Yekaterinburg, Russia;
International Headache Center «Europe-Asia», Yekaterinburg, Russia

Azimova Yu.E.

Pervyĭ MGMU im. I.M. Sechenova

Latysheva N.V.

Sergeev A.V.

Chair of biophysical methods in medicine, Faculty of continuing medical education of the Russian University of Peoples’ Friendship;
G.N. Speransky Children's Clinical Hospital №9

Amelin A.V.

Sankt-Peterburg

Koreshkina M.I.

Tsentr golovnoĭ boli Mezhdunarodnoĭ kliniki MEDEM, Sankt-Peterburg

Skorobogatykh K.V.

University Headache Clinic, Moscow, Russia

Ekusheva E.V.

Otdel patologii vegetativnoĭ nervnoĭ sistemy Nauchno-issledovatel'skogo tsentra Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva

Naprienko M.V.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Isagulyan E.D.

Burdenko Neurosurgical Institute, Moscow, Russia

Rachin A.P.

Kafedra nevrologii i psikhiatrii fakulteta povysheniia kvalifikatsii Smolenskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Danilov Al.B.

Department of Nervous Diseases, Institute of professional education, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Kurushina O.V.

Parfenov V.A.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Moskva

Tabeeva G.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Guekht A.B.

Moscow Research and Clinical Centre for Neuropsychiatry;
Pirogov Russian National Research Medical University

Iakhno N.N.

Kafedra nervnykh bolezneĭ i otdel nevrologii i klinicheskoĭ neĭrofiziologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Diagnosis and treatment of migraine: Recommendations of the Russian experts

Authors:

Osipova V.V., Filatova E.G., Artemenko A.R., Lebedeva E.R., Azimova Yu.E., Latysheva N.V., Sergeev A.V., Amelin A.V., Koreshkina M.I., Skorobogatykh K.V., Ekusheva E.V., Naprienko M.V., Isagulyan E.D., Rachin A.P., Danilov Al.B., Kurushina O.V., Parfenov V.A., Tabeeva G.R., Guekht A.B., Iakhno N.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(1‑2): 28‑42

DOI: 10.17116/jnevro20171171228-42

Views: 14573

Downloaded: 492

Download PDF (RU)
Contact the author
Table of contents

DIAGNOSIS AND TREATMENT OF MIGRAINE: RECOMMENDATIONS OF THE RUSSIAN EXPERTS
DIAGNOSIS AND TREATMENT OF MIGRAINE: RECOMMENDATIONS OF THE RUSSIAN EXPERTS

To cite this article:

Osipova VV, Filatova EG, Artemenko AR, et al. . Diagnosis and treatment of migraine: Recommendations of the Russian experts. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(1‑2):28‑42. (In Russ.)
https://doi.org/10.17116/jnevro20171171228-42

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata
Recommended articles:
Sleep diso­rders in patients with medi­cation-overuse headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):93-98
Mini­mally inva­sive inte­rventions for complications asso­ciated with intra-abdominal calculi after lapa­roscopic cholecystectomy. Piro­gov Russian Journal of Surgery. 2024;(5):14-20
Our expe­rience in the treatment of congenital nasal median hete­rotopias in children and an overview of various treatment tactics. Russian Bulletin of Otorhinolaryngology. 2024;(2):28-32
Problems in orga­nizing neurosurgical care for patients with Parkinson’s disease in the Russian Fede­ration. Burdenko's Journal of Neurosurgery. 2024;(3):5-13
Reco­very of consciousness under therapy with benzodiazepines. A case report and lite­rature review. Burdenko's Journal of Neurosurgery. 2024;(3):81-89
Chro­nic rhinosinusitis with nasal polyps as the first stage in the deve­lopment of eosi­nophilic granulomatosis with polya­ngiitis. Russian Rhinology. 2024;(2):157-166
Intraductal radiofrequency abla­tion for neoplasms of the major duodenal papi­lla with intraductal spread. Piro­gov Russian Journal of Surgery. 2024;(6):5-14
Medi­cation-overuse headache: description of patients and medi­cations used before admi­ssion to specialized center. Russian Journal of Pain. 2024;(2):16-21
Calcitonin gene-related peptide in pathophysiology of migraine. Russian Journal of Pain. 2024;(2):56-67
Arti­ficial inte­lligence in dermatology: oppo­rtunities and prospects. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(3):246-252

These recommendations on the diagnosis and treatment of migraine were elaborated by Russian headache experts in accordance with the evidence-based practice. Together with the latest classification, diagnostic principles and criteria of different clinical sub-forms the consensus contains basic data on migraine epidemiology, pathophysiological mechanisms, differential diagnosis and most effective and evidence based approaches to pharmacological and non-pharmacological management of migraine patients.

Keywords:

migraine
diagnostics
classification
clinical variants
chronic migraine
medication overuse headache
acute treatment
migraine prophylaxis
non-pharmacological treatment
neuromodulation

Authors:

Osipova V.V.

Research Department of Neurology, Scientific Research Center, I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Moscow Research Clinical Centre for Neuropsychiatry, Moscow Health Department, Moscow, Russia

Filatova E.G.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Artemenko A.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Lebedeva E.R.

Department of Neurology and Neurosurgery, The Urals State Medical University, Yekaterinburg, Russia;
International Headache Center «Europe-Asia», Yekaterinburg, Russia

Azimova Yu.E.

Pervyĭ MGMU im. I.M. Sechenova

Latysheva N.V.

Sergeev A.V.

Chair of biophysical methods in medicine, Faculty of continuing medical education of the Russian University of Peoples’ Friendship;
G.N. Speransky Children's Clinical Hospital №9

Amelin A.V.

Sankt-Peterburg

Koreshkina M.I.

Tsentr golovnoĭ boli Mezhdunarodnoĭ kliniki MEDEM, Sankt-Peterburg

Skorobogatykh K.V.

University Headache Clinic, Moscow, Russia

Ekusheva E.V.

Otdel patologii vegetativnoĭ nervnoĭ sistemy Nauchno-issledovatel'skogo tsentra Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva

Naprienko M.V.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Isagulyan E.D.

Burdenko Neurosurgical Institute, Moscow, Russia

Rachin A.P.

Kafedra nevrologii i psikhiatrii fakulteta povysheniia kvalifikatsii Smolenskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Danilov Al.B.

Department of Nervous Diseases, Institute of professional education, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Kurushina O.V.

Parfenov V.A.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Moskva

Tabeeva G.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Guekht A.B.

Moscow Research and Clinical Centre for Neuropsychiatry;
Pirogov Russian National Research Medical University

Iakhno N.N.

Kafedra nervnykh bolezneĭ i otdel nevrologii i klinicheskoĭ neĭrofiziologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

List of references:

  1. Global, regional, and national age—sex specific all-cause and cause-specific mortality for 240 causes of death, 1990—2013: a systematic analysis for the Global Burden of Disease Study 2013 GBD 2013 Mortality and Causes of Death Collaborators. Lancet. 2015;385:117. doi:10.1016/S0140-6736(14)61682-2
  2. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population — a prevalence study. Journal of Clinical Epidemiology. 1991;44:1147-1157. doi:10.1016/0895-4356(91)90147-2
  3. Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ. The prevalence of primary headache disorders in Russia: A countrywide survey. Cephalalgia. 2012;32(5):373-381. doi:10.1177/0333102412438977
  4. Lebedeva ER, Kobzeva NR, Gilev D, Olesen J. Prevalence of primary headache disorders diagnosed according to ICHD-3 beta in three different social groups. Cephalalgia. 2015;36(6):579-588. doi:10.1177/0333102415596442
  5. Glembotskaya GT, Kozub OV. Pharmacoeconomic evaluation of the « burden» of migraine in the Russian Federation. Clinical pharmacology and therapy. 2013;22(2):83-86. (In Russ.).
  6. Maksyukova EV, Osipova VV. Migraine patients older age groups: clinical and psychological analysis. Russian Journal of Pain. 2011;2:33. (In Russ.).
  7. Osipova VV, Snopkova E, Tabeeva G. Migraine in the Elderly. In: Siva A., Lampl C. (eds) Case-Based Diagnosis and Management of Headache Disorders. Headache. Series editors: P. Marteletti, R. Jensen, Springer International Publishing. 2015;109-118. doi:10.1007/978-3-319-06886-2_16
  8. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. European Journal of Epidemiology. 2005;20(3):243-249. doi:10.1007/s10654-004-6519-2
  9. Snopkova EV, Sergeev AV, Osipova VV. Comparative clinical and psychological analysis of migraine in young and old patients. The Neurological Journal. 2012;17(6):32-37. (In Russ.). doi:10.18821/1560-9545-2012-17-6-32-37
  10. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. doi:10.1177/0333102413485658
  11. Vein AM, Kolosova OA, Yakovlev NA, Slyusar TA. Migraine. M. 1995. (In Russ.).
  12. Tabeeva GR, Yakhno NN. Migraine. M.: GEOTAR-Media, 2011. (In Russ.).
  13. Sergeev AV, Meserina MI, Tabeeva GR. Headache associated with excessive intake of analgesics: clinical, neurophysiological and psychological analysis, especially the cancellation period. Epilepsy and paroxysmal states. 2011;3(3):21-28. (In Russ.).
  14. Diener H-C, Limmroth V, Katsarava Z. Medical-Overused Headache. In: Chronic daily headache for clinicians. Goadsby P.J., Dodick D.W. (Eds). Decker, Hamilton. 2005;117.
  15. Obermann M, Katsarava Z. Management of medication overuse headache. Expert Review Of Neurother apeutics. 2007;7(9):1145-1155. doi:10.1586/14737175.7.9.1145
  16. Katsarava Z, Ayzenberg I. Induced drug-induced headache. Materials of All-Russian scientific-practical conference «Headache — 2007». M. 2007;80-91. (In Russ.).
  17. Artemenko AR. Chronic migraine: features, pathogenesis, treatment: Dis. ... Doctor of Medical Sciences. M. 2010. (In Russ.).
  18. Amelin AV, Bogdanova UN, Koreshkina MI, Procenko EV, Skoromec AA, Tarasova SV. Diagnosis of primary and symptomatic forms of chronic daily headache. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2011;111(4):69-71. (In Russ.).
  19. Kurushina OV, Urvachev VA, Ivashneva LA. The role of the psycho-emotional peculiarities of patients in the formation of primary cephalgia. Bulletin of Pyatigorsk State Linguistic University. 2010;2:332-333. (In Russ.).
  20. Gromova SA, Tabeeva GR. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2011;111(7):44-48. (In Russ.).
  21. Osipova V, Ayzenberg I, Amelin A, Tarasova S, Sergeev A, Tabeeva G. The highest prevalence of CDH in Russia: why? Cephalalgia. 2015;35(6):287. doi:10.1177/0333102415581304
  22. Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds.) The Headaches. 3rd Edition. Philadelphia: Lippincott Williams & Wilkins; 2006.
  23. Massiou H, MacGregor A. Influence of female hormones on migraines. In: Olesen J., Goadsby P.J., Ramadan N., Tfelt-Hansen P., Welch K.M. (eds). The Headaches, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2005;331-342.
  24. Lebedeva ER, Kobzeva NR, Gilev DV, Olesen Jes. Factors associated with migraine and tension type headache in three social groups. Ural Medical Journal. 2015;2:5-14. (In Russ.).
  25. Osipova VV, Rachin AP, Udelson IB. Migraine: the correct diagnosis to adequate therapy. Directory of outpatient physician. Handbook of outpatient physician. 2007;1:51-56. (In Russ.).
  26. Osipova VV, Tabeeva GR. Primary headaches: diagnostics, clinic, therapy: A Practical Guide. М.: OOO «Publisher» Medical News Agency»; 2014. (In Russ.).
  27. Osipova V, Jensen R, Tassorelli C. The use of diaries in the management of headache. Handbook of Headache (Practical Management). Eds. P. Martelletti, T.J. Steiner. 2011;4:197-209. doi:10.1007/978-88-470-1700-9_13
  28. Tabeeva GR. Migraine Prevention. М.: Pulse; 2007. (In Russ.).
  29. Azimova YE, Sergeev AV, Osipova VV, Tabeeva GR. Diagnosis and treatment of headaches in Russia: results of a questionnaire survey of doctors. Russian Journal of Pain. 2010;3-4:12-17. (In Russ.).
  30. Artemenko AR, Kurenkov AL, Belomestova KV. Principles of interviewing in the diagnosis of chronic migraine. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014;9 81-87. (In Russ.).
  31. Osipova VV, Voznesenskaya TG. Comorbidity of migraine: review and approaches to research. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2007;107(3):64-73. (In Russ.).
  32. Artemenko AR, Kurenkov AL. Chronic migraine. М.: ID «ABV-press»; 2012. (In Russ.).
  33. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. 2nd ed. London: Martin Dunitz; 2002.
  34. Steiner TJ, MacGregor EA, Davies PTG. Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication overuse headache. British Association for the Study of Headache, 3rd edn. 2007;1-523.
  35. Koreshkina MI. Modern neuroimaging techniques and preventive treatment of migraine. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2011;111(9):25-31. (In Russ.).
  36. Koreshkina MI, Osipova VV, Trofimova TN, Chalikov AD, Nazinkina YV. The role of MRI in the diagnostic algorithm migraine identified changes. Ural Medical Journal. 2013;1:25-32. (In Russ.).
  37. Evans RW. Diagnostic testing for headaches. The Medical clinics of North America. 2001;85(4):865-885. doi:10.1016/s0025-7125(05)70348-5
  38. Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM. Does this patient with headache have a migraine or need neuroimaging? JAMA. 2006;296:1274-1283. doi:10.1001/jama.296.10.1274
  39. Lipton RB, Bigal ME. Differential diagnosis of primary headaches. An algorithm based approach. In: R.B. Lipton, M.E. Bigal (eds) Migraine and other headache disorders. New York: Informa Healthcare. 2006;145-154.
  40. Koreshkina MI, Chalikov AD, Nazinkina YV, Osipova VV, Amelin AV, Kosmacheva EA. The study of cerebral blood flow using the high field MRI perfusion during an attack of migraine with aura. Epilepsy and paroxysmal states. 2012;4(4):12-17. (In Russ.).
  41. Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA study. Cephalalgia. 2010;30:129-136. doi:10.1111/j.1468-2982.2009.01904.x
  42. Koreshkina MI, Atlas SW, Khalikov AD, Kosmacheva EA. Magnetic resonance investigation 3,0 T detects white matter lesions of brain in case of chronic migraine. Cephalalgia. 2009;29:127.
  43. Diseases of the brain — the medical and social aspects. Eds. Gusev E.I., Geht A.B. М.: ООО «Buki-Vedi»; 2016. (In Russ.).
  44. Osipova VV, Azimova YE, Tabeeva GR, Tarasova SV, Amelin AV, Kutsemelov IB, Moldoveanu IV, Odobesku SS, Naumova GI. Diagnosing headaches in Russia and countries of the former Soviet Union: state of the problem and its solutions. Annals of clinical and experimental neurology. 2012;6(2):16-21. (In Russ.).
  45. Lebedeva ER, Kobzeva NR, Gilev DV, Olesen J. Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:19-26. (In Russ.). doi:10.14412/2074-2711-2015-1-19-26
  46. Evans RW. The neurological history and examination. In: Saunders manual of neurological practice. Ed. R.W. Evans. Philadelphia: WB Saunders; 2003;1-10.
  47. Steiner TJ. European principles of management of patients with the most common forms of headache in general practice: a practical guide for physicians. Translation and English Azimova Y.E., Osipova V.V. Scientific edition Osipova V.V., Voznesenskaya T.G., Tabeeva G.R. M.: OOO «OGGI. Promotional Products; 2010;56. (In Russ.).
  48. Silberstein SD. A new frontier for headache. Frontiers in Neurology. 2010;1:135. doi:10.3389/fneur.2010.00135
  49. Amelin AV, Ignatov YD, Skoromec AA, Sokolov AY. Migraine (pathogenesis, clinical features, treatment). М.: MEDpress; 2011. (In Russ.).
  50. Yakhno NN, Parfenov VA, Alekseev VV. Headache. M.: Remedium; 2011. (In Russ.).
  51. Danilov AB, Danilov AlB. Guidelines for doctors of different specialties. Pain management: a bio-psycho-social approache. M.: «AMM PRESS»; 2014. (In Russ.).
  52. Olesen J, Bousser MG, Diener H-C, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJA, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26:742-746. doi:10.1111/j.1468-2982.2006.01172.x
  53. Tabeeva GR, Azimova YE, Margulis MI. Refractory migraine: from pathogenesis to rational therapy. Russian Medical Journal. 2011;1:18-19.
  54. Ferrari A. Headache: one of the most common and troublesome adverse reactions to drugs. Current Drug Safety. 2006;1(1):43-58. doi:10.2174/157488606775252610
  55. Ferrari A, Spaccapelo L, Sternieri E. Pharmacoepidemiology of triptans in a headache centre. Cephalalgia. 2010;30(7):847-854. doi:10.1177/0333102409357956
  56. Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Current Pain and Headache Reports. 2012;16(1):86-92. doi:10.1007/s11916-011-0233-z
  57. Maizels M. Clonazepam for refractory headache: three cases illustrative of benefit and risk. Headache. 2010;50(4):650-656. doi:10.1111/j.1526-4610.2010.01633.x
  58. Koreshkina MI. Epidemiology, pathogenetic mechanisms, diagnosis and treatment of migraine. The practitioner today. Journal of Postgraduate Education. 2015;3:2-13. (In Russ.).
  59. Ekusheva EV, Damulin IV. The actual approaches to therapy of refractory migraine. Russian Medical Journal. 2014;5:45-52. (In Russ.).
  60. Steiner TJ. The reform of headache services: a first-class service in the «modern and dependable» NHS (MSc thesis). London: Univ. London; 2002.
  61. Diener H-C, Gaul C, Jensen R, Gobel H, Heinze A, Silberstein S. Integrated headache care. Cephalalgia. 2011;31(9):1039-1047. doi:10.1177/0333102411409075
  62. Tabeeva GR. Migraine features associated with the menstrual cycle. Treatment of diseases of the nervous system. 2014;2(14):32-35. (In Russ.).
  63. Amelin AV. Modern aspects of diagnosis, pathogenesis and treatment of migraine. М.: OOO NTC AMT; 2007. (In Russ.).
  64. Amelin AV. Nonsteroidal anti-inflammatory drugs for migraine. Therapist. 2012;5:25-27. (In Russ.).
  65. Filatova EG. Treatment of migraine attacks. Russian Medical Journal. 2013;21(16):862-865. (In Russ.).
  66. Filatova EG, Amelin AV, Tabeeva G.R. Ready — the first Russian multicenter study of the efficacy of the drug relpaks (eletriptan) for the treatment of migraine. Treatment of Nervous Diseases. 2006;2:19-22. (In Russ.).
  67. Ekusheva EV, Damulin IV. Refractory migraine: modern methods of drug therapy. Neurological Gazette them. Bekhterev. 2014;XLVI(4):44-52. (In Russ.).
  68. Pain (practical guide for physicians). Eds. Yakhno N.N., Kukuchkin M.L. M.: Publisher of Medical Sciences; 2011. (In Russ.).
  69. Becker WJ, Gawel M, Mackie G, South V, Christie SN. Migraine treatment. The Canadian Journal of Neurological Science. 2007;34:10-19. 35.
  70. Latysheva NV. The modern rules for the treatment of a migraine attack — the rejection of stereotypes. Treatment of diseases of the nervous system. 2011;2(7):21-27. (In Russ.).
  71. On approval of the standard of primary health care in migraine (differential diagnosis and cupping). Order of the Ministry of Health of the Russian Federation №1550n of 24 December 2012 the treatment of stroke (analgesics, triptans). (In Russ.).
  72. Osipova VV. Migraine and tension-type headache. In: Clinical guidelines. Neurology and Neurosurgery. Eds. Gusev E.I., Konovalov A.N. 2 nd ed., Revised. and ext. M.: GEOTAR Media; 2015. (In Russ.).
  73. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine — report of an EFNS task force. European Journal of Neurology. 2009;16(9):968-981. doi:10.1111/j.1468-1331.2009.02748.x
  74. Ekusheva EV, Damulin IV. Current approaches to treatment of migraine during pregnancy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(11):86-94. (In Russ.). doi:10.17116/jnevro2015115111124-132
  75. Vein AM, Puchalskaya TV, Osipova VV, Kolosova OA. Sumatriptan. 11 years of use in the clinic. Treatment of Nervous Diseases. 2002;3(2):18-21. (In Russ.).
  76. Osipova VV. Protivomigrenoznye funds. Guide for the rational use of drugs (formulary) . Eds. Chuchalin A.G., Belousov Y.B., Habriev R.U., Ziganshina L.E. M.: GEOTAR-Media; 2006. (In Russ.).
  77. Canadian Headache Society Guideline for Migraine Prophylaxis. The Canadian Journal of Neurological Sciences. 2012;39(2):1-63. doi:10.1017/s0317167100015109
  78. Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ. Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society Guideline: Acute Drug Therapy for Migraine Headache. The Canadian Journal of Neurological Sciences. 2013;40(3):1-80. doi:10.1017/s0317167100017819
  79. European Headache Federation. EHF missions. http://www.ehf-org.org/mission.asp
  80. Bendtsen L, Birk S, Kasch H, Aegidius K, Sørensen PS, Thomsen LL, Poulsen L, Rasmussen M-J, Kruuse C, Jensen R. Reference programme: Diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. The Journal of Headache and Pain. 2012;13(1):1-29. doi:10.1007/s10194-011-0402-9
  81. Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2005;45:983-991. doi:10.1111/j.1526-4610.2005.05178.x
  82. Danilov AB, Podymova IG, Filatova EG, Ekusheva EV, Tabeeva GR, Osipova VV, Azimova JuJ., Amelin AV, Koreshkina MI, Rachin AP. Lechenie migrenoznogo pristupa: jeffektivnost' i bezopasnost'. Medicinskij konsilium. 2013;15(2):19-22.
  83. Azimova YE, Rachin AP. Migraine, caffeine, ergotamine: classical trio. Polyclinic. 2016;1:28-30. (In Russ.).
  84. Latysheva NV, Filatova EG. Venlafaxine (velafax) in the treatment of chronic daily headache: mechanism of action. Treatment of diseases of the nervous system. 2010;2:24-27. (In Russ.).
  85. Artemenko AR, Kurenkov AL, Belomestova KV. Classification, diagnosis and treatment of chronic migraine: review of new data. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;11:91-96. (In Russ.).
  86. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal. 2008;336:924-926. doi:10.1136/bmj.39489.470347
  87. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2003;289:65-69. doi:10.1001/jama.289.1.65
  88. Evers S, Jensen R. Treatment of medication overuse headache--guideline of the EFNS headache panel. European Federation of Neurological Societies. European Journal of Neurology. 2011;18(9):1115-1121. doi:10.1111/j.1468-1331.2011.03497.x
  89. Evers S. Treatment of migraine with prophylactic drugs. Expert Opinion on Pharmacotherapy. 2008;9(15):2565-2573. doi:10.1517/14656560802377046
  90. Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia. 2008;28:484-495. doi:10.1111/j.1468-2982.2008.01555.x
  91. Artemenko AR, Kurenkov AL, Antipova OS. Diagnosis and treatment of chronic migraine. М.: Hot line. Telekom; 2014. (In Russ.).
  92. Naprienko MV, Latysheva NV, Filatova EG. New treatment options for chronic daily headache. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2010;110(1):49-54. (In Russ.).
  93. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Headache. 2007;47:170-180. doi:10.1111/j.1526-4610.2006.00684.x
  94. Kowacs PA, Piovesan EJ, Tepper SJ. Rejection and acceptance of possible side effects of migraine prophylactic drugs. Headache. 2009;49:1022-1027. doi:10.1111/j.1526-4610.2009.01431.x
  95. Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, Mathew N, Winner PK, Deaton R, Sommerville K, Depakote ER. Migraine Study Group. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58:1652-1659. doi:10.1212/wnl.58.11.1652
  96. Bussone G, Diener HC, Pfeil J, Schwalen S. Topiramate 100 mg/day in migraine prevention: a pooled analysis of doubleblind randomised controlled trials. International Journal of Clinical Practice. 2005;59:961-968. doi:10.1111/j.1368-5031.2005.00612.x
  97. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ and TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27(7):814-823. doi:10.1111/j.1468-2982.2007.01326.x
  98. Sorensen PS, Larsen BH, Rasmussen MJ, Kinge E, Iversen H, Alslev T, Nøhr P, Pedersen KK, Schrøder P, Lademann A, Olesen J. Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability. Headache. 1991;31:650-657. doi:10.1111/j.1526-610.1991.hed3110650.x
  99. Latysheva NV, Filatova EG, Tabeeva GR, Osipova VV, Artemenko AR, Tarasova SV, Azimova YE, Katsarava Z. Practical issues of management of patients with chronic migraine. Recommendations from Russian experts. Neuromuscular Diseases. 2015;5(3):2-7. (In Russ.). doi:10.17650/2222-8721-2015-5-3-31-36
  100. Nestoriuc Y, Martin A, Rief W, Andrasik F. Biofeedback treatment for headache disorders: a comprehensive efficacy review. Applied Psychophysiology and Biofeedback. 2008;33:125-140. doi:10.1007/s10484-008-9060-3
  101. Naprienko MV. Acupuncture in the medical rehabilitation of patients with chronic migraine and chronic tension-type headache. Manual therapy. 2010;3(39):64-69. (In Russ.).
  102. Golovacheva VA, Parfenov VA. Cognitive-behavioral therapy of migraine. The Neurological Journal. 2015;3(20):37-43. (In Russ.). doi:10.18821/1560-9545-2015-20-3-37-43
  103. Golovacheva V, Parfenov V, Tabeeva G, Osipova V. Combined cognitive-behavioral and pharmacological therapies for chronic migraine and chronic tension-type headache: are treatment responses different? Cephalalgia. 2015;35(6):272. doi:10.1177/0333102415581304
  104. Zhu S, Marmura MJ. Non-Invasive Neuromodulation for Headache Disorders. Current Neurology Neuroscience Reports. 2016;16(2):11. doi:10.1007/s11910-015-0620-7
  105. Shoenen J, Allena M, Magis D. Neurostimulation therapy in intractable headaches. Handbook of clinical neurology. Vol. 97 (3rd series). Headache. Eds. Nappi G., Moskowitz MA. Elsevier B.V. 2011;443-450.
  106. Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF. PREEMPT 1 Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010;30(7):793-803. doi:10.1111/j.1526-4610.2011.01898_2.x
  107. Negro A, Curto M, Lionetto L, Martelletti P. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience. The Journal of Headache and Pain. 2015;17(1):1. doi:10.1186/s10194-016-0591-3
  108. Artemenko AR, Kurenkov AL, Belomestova KV. On the absence of interchangeability of botulinum toxin type A drugs. Medical Council. 2015;5:112-123. (In Russ.). doi:10.21518/2079-701X-2015-5-112-123
  109. Blumenfeld A, Silberstein SD, Dodick DW, Aurora SA, Turkel CC, Binder WJ. Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program. The Journal of Headache and Pain. 2010;50(9):1406-1418. doi:10.1111/j.1526-4610.2010.01766.x
  110. Negro A, Curto M, Lionetto L, Crialesi D, Martelletti P. Onabotulinumtoxin A 155 U in medication overuse headache: a two years prospective study. Springer Plus. 2015;4:826. doi:10.1186/s40064-015-1636-9
  111. Filatova EG. Abuse headache. New diagnosis and treatment of headache. IV Annual Conference «Veynovskie Readings — 2008». (In Russ.). http://www.paininfo.ru/events/veinconference/1321.html
  112. Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Current Opinion of Neurology. 2007;20(3):326-330. doi:10.1097/wco.0b013e328136c21c
  113. Rabe K, Pageler L, Gaul C, Lampl C, Kraya T, Foerderreuther S, Diener H-C, Katsarava Z. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2013;33(3):202-207. doi:10.1177/0333102412462638
  114. Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain. 2012;153(1):56-61. doi:10.1016/j.pain.2011.08.018

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.